Loading…

Sex-specific association of sex hormones and gonadotropins, with brain amyloid and hippocampal neurodegeneration

Abstract This study aimed to examine the sex-specific association between serum sex hormones and gonadotropins and the cerebral beta-amyloid (Aβ) burden and hippocampal neurodegeneration in subjects with normal cognition (NC) and impaired cognition (IC). Two-hundred and sixty-five older subjects rec...

Full description

Saved in:
Bibliographic Details
Published in:Neurobiology of aging 2017-10, Vol.58, p.34-40
Main Authors: Lee, Jun Ho, Byun, Min Soo, Yi, Dahyun, Choe, Young Min, Choi, Hyo Jung, Baek, Hyewon, Sohn, Bo Kyung, Lee, Jun-Young, Kim, Hyun Jung, Kim, Jee Wook, Lee, Younghwa, Kim, Yu Kyeong, Sohn, Chul-Ho, Woo, Jong Inn, Lee, Dong Young
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract This study aimed to examine the sex-specific association between serum sex hormones and gonadotropins and the cerebral beta-amyloid (Aβ) burden and hippocampal neurodegeneration in subjects with normal cognition (NC) and impaired cognition (IC). Two-hundred and sixty-five older subjects received clinical assessments, serum measurements of sex hormones, gonadotropins,11 C-Pittsburgh compound B-positron emission tomography, and magnetic resonance imaging. In females, higher free testosterone and gonadotropin levels were associated with lower cerebral Aβ positivity. In males, free testosterone was positively related to hippocampal volume with significant interaction with cognitive status. Further subgroup analyses showed that the association was significant only in IC, but not in NC. Free estradiol was not associated with Aβ burden or hippocampal neurodegeneration in either sex. These results suggest that testosterone might inhibit the early pathological accumulation of Aβ in females and delay neurodegeneration in males.
ISSN:0197-4580
1558-1497
DOI:10.1016/j.neurobiolaging.2017.06.005